Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceuticals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108299482B details a novel nucleophilic route for 18F-BPA, offering higher specific activity and safer processing for PET imaging agents.
Patent CN114380877B details a high-yield 6-step route for Azvudine. Offers significant cost reduction and scalable manufacturing for global supply chains.
Patent CN110183347B discloses novel benzyl compounds for liquid phase peptide synthesis, offering superior solubility, simplified purification, and high purity for commercial manufacturing.
Advanced synthesis of flunixin meglumine intermediate via high-pressure fluorination. Delivers high purity and scalable manufacturing for veterinary pharmaceuticals.
Patent CN108299482A details a novel nucleophilic fluorination method for F-BPA, offering high specific activity and cost reduction in radiopharmaceutical manufacturing for PET imaging.
Optimized synthesis of DOTA-EB-PSMA precursor reduces HPLC steps ensuring high purity and scalable supply for prostate cancer radioligand therapy manufacturing.
Patent CN115043864A details a streamlined synthesis for F-BPA intermediates, offering reduced reaction time and improved radiochemical yield for BNCT applications.
Patent CN115010739A details a streamlined F-BPA synthesis route. This innovation offers significant cost reduction in PET tracer manufacturing and ensures high-purity supply continuity.
Patent CN107557412B details a continuous immobilized enzyme method for NADPH synthesis, offering high purity and cost reduction in biopharmaceutical manufacturing.
Patent CN110903247B reveals a urea peroxide oxidation method for oxfendazole, significantly reducing impurity B and enhancing safety for veterinary pharmaceutical manufacturing.
Patent CN116003439A reveals a high-yield refining method for ceftiofur hydrochloride, ensuring >99.7% purity and reduced manufacturing costs for veterinary pharmaceutical supply chains.
Patent CN1097583C reveals a one-pot method for oxazoline intermediates, offering significant cost reduction and supply chain reliability for veterinary drug manufacturing.
Patent CN103694167A details a high-yield synthesis of Flunixin Meglumine using a novel CuO/TsOH dual-catalyst system in water, offering significant cost and purity advantages for veterinary pharmaceutical manufacturers.
Patent CN102249937A details a low-cost, non-toxic synthesis for Ivabradine intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN111978218A introduces a cost-effective florfenicol synthesis using sulfuryl fluoride, replacing hazardous Ishikawa reagents for safer, scalable veterinary API manufacturing.
Novel Grignard-based process for halofuginone intermediate offering superior yield and scalable production for veterinary pharmaceutical supply chains.
Novel pathway for Firocoxib production reduces purification steps. Enhances supply chain reliability for veterinary pharmaceutical intermediates manufacturers globally.
Patent CN114805231A reveals a high-yield, eco-friendly synthesis for p-NH2-Bn-NOTA, offering significant cost reduction and supply chain reliability for radiopharmaceutical manufacturers.
Patent CN116813544B introduces a green heating-promoted method for high-purity trifluoromethyl quinoline intermediates enabling significant cost savings and reliable supply chain solutions for global pharmaceutical manufacturers.
Solve C-F bond synthesis challenges with 94% yield, wide substrate scope, and industrial scalability for pharma/agrochemical R&D and procurement teams.